Elon Musk welcomed FDA approval for brain-implant company Neuralink to start testing the technology on humans, but some were reluctant to participate in clinical research, saying it was “too intrusive.” .
“We are pleased to share that we have received FDA approval to initiate a first-in-human clinical study.” Tweeted by Neuralink on thursday.
“This is the result of a great job by the Neuralink team working closely with the FDA, and represents an important first step to one day enabling our technology to help many people,” the post said. I’m here.
“Congratulations to the Neuralink team!” Musk replied.
Neuralink, based in the San Francisco Bay Area and Austin, Texas, announced in December that it was developing a brain-chip interface that would give paralyzed and other neurologically impaired patients the ability to move. It announced for the first time that it would host a clinical trial. and communicate again.
Musk says the technology can also restore vision in humans, and has been tested on animals in recent years, while seeking FDA approval to begin clinical trials in humans.
“Our clinical trial recruitment has not yet begun, and we will be announcing more details about this soon,” the company said.
Many on Musk-owned Twitter said they were in no rush to be used as guinea pigs.
“I’m not actually trying to put a chip in my brain. It’s too intrusive for my liking.” A user tweeted.
“Brother, please make a detachable earphone AI.” another person said.
Another called for a law regulating Neuralink.
“It would be great if it was only used to help people with disabilities. We need to enact laws to protect them.” user tweeted.
not yet someone else called it “A major turning point in human history, or one of the worst creations in history.”
The FDA told the Post on Friday, “Neuralink has announced that the Investigational Device Exemption (IDE) for its Implant/R1 Robot has been approved by the FDA and may begin human clinical trials of its device in the future. I understand,” he admitted.
The federal agency did not comment further on the technology.
Musk, 51, has repeatedly predicted that brain chips would get FDA approval after Neuralink announced in 2019 that it had successfully implanted chips in monkeys.
But federal regulators rejected the company’s application for approval in early 2022, citing safety concerns.
By the end of the year, he told an audience during a question-and-answer session at a Neuralink event that he would implant a chip in one of his children’s brains if needed.
“In my opinion, if they ask me if they are in a serious situation, would they be comfortable with implanting this at the moment…if they break their neck, for example, I would Will it? Will it be comfortable? Will it,” Musk said at an event in December.
“At least in my opinion, we’re at a stage where it’s not dangerous,” Musk added.
